BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home
»
Authors
» Nuala Moran
Nuala Moran
Articles
ARTICLES
Genzyme Invests $37.7M In CAT As Companies Restructure Pact
Sep. 23, 2003
By
Nuala Moran
Genzyme Invests $37.7M In CAT As Companies Restructure Pact
Sep. 23, 2003
By
Nuala Moran
Oxford BioMedica Raises £22.1M To Fund 7 Development Programs
Sep. 17, 2003
By
Nuala Moran
PPL Puts Itself On The Block, Leaves Legacy Of Cloned Dolly
Sep. 17, 2003
By
Nuala Moran
Xention Raises £4M In Second Round For Work In Ion Channels
Sep. 17, 2003
By
Nuala Moran
Oxford BioMedica Raises £22.1M To Fund 7 Development Programs
Sep. 17, 2003
By
Nuala Moran
PPL Puts Itself On The Block, Leaves Legacy Of Cloned Dolly
Sep. 17, 2003
By
Nuala Moran
Avidex Enters Deal With Dow On Radioisotope For Cancer
Sep. 10, 2003
By
Nuala Moran
UK Strategy On Biotech Clusters On Wrong Track, Committee Says
Sep. 10, 2003
By
Nuala Moran
CAT Argues Rates With Abbott, Settles IP Issues With Others
Sep. 10, 2003
By
Nuala Moran
View All Articles by Nuala Moran